LUXTURNA

Google image searchProduct monograph

Active ingredient

voretigene neparvovec, 5000000000000 VG/ML

DIN: 02505851

Dosage form(s): SOLUTION

Route(s) of administration: SUBRETINAL

Schedule: Prescription / Schedule D

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 14-MAR-2022

ATC:

• S01 — OPHTHALMOLOGICALS (ATC, ATC/DDD, )
• S01X — OTHER OPHTHALMOLOGICALS (ATC, ATC/DDD)
• S01XA — Other ophthalmologicals (ATC, ATC/DDD)
• S01XA27 — VORETIGENE NEPARVOVEC (ATC/DDD)

External Links for Luxturna

Search on Google

• Luxturna side effects
• Luxturna dosage
• voretigene neparvovec side effects
• voretigene neparvovec dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find luxturna photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.